CryoLife's Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around...(ndergoing Ross Procedures than other val...)

Date:9/3/2009

ndergoing Ross Procedures than other valve replacement options. These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties. These risks and uncertainties are detailed in CryoLife's Securities and Exchange Commission filings, including CryoLife's Form 10-K filing for the year ended December 31, 2008, our Form 10-Q for the quarter ended March 31, 2009, our Form 10-Q for the quarter ended June 30, 2009, and the Company's other SEC filings. The Company does not undertake to update its forward-looking statements.

For additional information about the company, visit CryoLife's Web site: www.cryolife.com.

    Media Contacts:

    D. Ashley Lee
    Executive Vice President, Chief Financial Officer and
    Chief Operating Officer
    Phone:  770-419-3355

    Dana Hartline
    Vice President
    Edelman
    Phone: 404-262-3000

'/>"/>

SOURCE CryoLife, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
2. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
3. avVaa World Health Care Products, Inc. Announces the completion of its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief
4. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
5. Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing
6. Encorium Reports Second Quarter 2009 Financial Results
7. Los Gatos Research Introduces Second Generation Liquid-Water Isotope Analyzer
8. Spherix Reports Second Quarter 2009 Earnings
9. Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
10. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
11. China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results